PDS BIOTECHNOLOGY CORP

$11.58 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About PDS BIOTECHNOLOGY CORP

PDS Biotechnology Corp operates as a clinical-stage biotechnology company. The Company develops immuno-oncology therapies to treat various early and late stage cancers including head and neck, prostate, breast, cervical, and anal cancers. PDS Biotechnology serves patients worldwide.

Stock Analysis

last close $12.05
1-mo return -18.4%
3-mo return 27%
avg daily vol. 509.77T
52-week high 17.85
52-week low 1.87
market cap. $350M
forward pe -
annual div. -
roe -25.7%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 20.9%
baraka

Subscribe now for daily local and international financial news

Subscribe